B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107

被引:21
作者
Joaquin, M [1 ]
Bessa, M [1 ]
Saville, MK [1 ]
Watson, RJ [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Ludwig Inst Canc Res, Sect Virol & Cell Biol, London W2 1PG, England
关键词
B-Myb; p107 pocket protein; cell cycle; cyclin E/Cdk2; cyclin A2/Cdk2;
D O I
10.1038/sj.onc.1206001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
B-Myb is a cell-cycle regulated transcription factor which is implicated in cell proliferation and has an essential role in early embryonic development. In this study we examined the functions of B-Myb required to overcome G1 arrest in Saos-2 cells induced by the retinoblastoma-related p107 protein. Our results demonstrated that this activity was independent of B-Myb transactivation function, but correlated with its capacity to form an in vivo complex with p107. A large proportion of B-Myb formed complexes with p107 in cotransfected cells, however, B-Myb bound weakly to the related p130 protein and not at all to pRb. In contrast to the E2F transcription factors, which bind the p107 C-terminal pocket domain, B-Myb recognizes an N-terminal p107 region which overlaps the larger cyclin-binding domain. B-Myb and cyclin A2 formed mutually exclusive complexes with p107, and B-Myb enhanced the activity of co-transfected cyclin E kinase activity, implying that B-Myb affects the cell cycle by preventing sequestration of active cyclin/cdk2 complexes. This study defines a novel function of B-Myb and further suggests that the p107 N-terminus provides an interaction domain for transcription factors involved in cell cycle control.
引用
收藏
页码:7923 / 7932
页数:10
相关论文
共 42 条
[1]   B-myb, a repressed trans-activating protein [J].
Ansieau, S ;
KowenzLeutz, E ;
Dechend, R ;
Leutz, A .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1997, 75 (11-12) :815-819
[2]  
ARSURA M, 1992, BLOOD, V79, P2708
[3]   Identification of cyclin A/Cdk2 phosphorylation sites in B-Myb [J].
Bartsch, O ;
Horstmann, S ;
Toprak, K ;
Klempnauer, KH ;
Ferrari, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 260 (02) :384-391
[4]   INTERACTION OF C-MYC WITH THE PRB-RELATED PROTEIN P107 RESULTS IN INHIBITION OF C-MYC-MEDIATED TRANSACTIVATION [J].
BEIJERSBERGEN, RL ;
HIJMANS, EM ;
ZHU, L ;
BERNARDS, R .
EMBO JOURNAL, 1994, 13 (17) :4080-4086
[5]   Regulation of the cell cycle by B-Myb [J].
Bessa, M ;
Joaquin, M ;
Tavner, F ;
Saville, MK ;
Watson, RJ .
BLOOD CELLS MOLECULES AND DISEASES, 2001, 27 (02) :416-421
[6]   Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator [J].
Bessa, M ;
Saville, MK ;
Watson, RJ .
ONCOGENE, 2001, 20 (26) :3376-3386
[7]  
Bies J, 1996, ONCOGENE, V12, P355
[8]   Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor [J].
Castaño, E ;
Kleyner, Y ;
Dynlacht, BD .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (09) :5380-5391
[9]  
DATTA PK, 1995, MOL CELL BIOL, V15, P5444
[10]   B-myb alters the response of myeloid precursor cells to G-CSF [J].
Engelhard, A ;
Campbell, K ;
Calabretta, B .
EXPERIMENTAL CELL RESEARCH, 2000, 254 (01) :153-162